Innovation
2 patent families — focus: Chemistry & metallurgy; filing pace steady. Cited 135 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
Investor mix
6 investors on record; lead investors include Allergan Aesthetics, Fortunis Capital, DCVC, Allergan.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Private equity | 1 | 17% |
| Other / undisclosed | 3 | 50% |